Salem Investment Counselors’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8
Closed -$133 1186
2023
Q2
$133 Hold
8
﹤0.01% 1121
2023
Q1
$155 Hold
8
﹤0.01% 1085
2022
Q4
$189 Hold
8
﹤0.01% 1052
2022
Q3
$0 Hold
8
﹤0.01% 1138
2022
Q2
$0 Hold
8
﹤0.01% 1132
2022
Q1
$0 Hold
8
﹤0.01% 1130
2021
Q4
$1K Hold
8
﹤0.01% 1054
2021
Q3
$1K Hold
8
﹤0.01% 952
2021
Q2
$1K Buy
+8
New +$998 ﹤0.01% 879

Other funds holding QTTB

Salem Investment Counselors's QTTB Position: Q3 2023 in Review

Salem Investment Counselors sold out of Q32 Bio (QTTB) in Q3 2023, closing a stake of 8 shares — an estimated $133 sold.

Salem Investment Counselors first reported a position in QTTB in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q4 2021. 58 funds tracked by Wall St. Rank hold QTTB as of Q3 2023.

  • Salem Investment Counselors reported no remaining Q32 Bio position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 8 Q32 Bio shares in Q3 2023, an estimated $133.
  • Salem Investment Counselors first reported a position in Q32 Bio in Q2 2021 and held it in 9 quarters.
  • Salem Investment Counselors's Q32 Bio position peaked at $1K in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.